Barriers  ||| S:0 E:9 ||| NNS
upon  ||| S:9 E:14 ||| IN
providing  ||| S:14 E:24 ||| VBG
assistance  ||| S:24 E:35 ||| NN
with  ||| S:35 E:40 ||| IN
making  ||| S:40 E:47 ||| VBG
arrangements  ||| S:47 E:60 ||| NNS
for  ||| S:60 E:64 ||| IN
discharging  ||| S:64 E:76 ||| NN
and  ||| S:76 E:80 ||| CC
changing  ||| S:80 E:89 ||| VBG
from  ||| S:89 E:94 ||| IN
hospitals  ||| S:94 E:104 ||| NNS
while  ||| S:104 E:110 ||| IN
a  ||| S:110 E:112 ||| DT
patient  ||| S:112 E:120 ||| NN
is  ||| S:120 E:123 ||| VBZ
undergoing  ||| S:123 E:134 ||| VBG
cancer  ||| S:134 E:141 ||| NN
therapy  ||| S:141 E:149 ||| NN
There  ||| S:149 E:155 ||| EX
has  ||| S:155 E:159 ||| VBZ
been  ||| S:159 E:164 ||| VBN
an  ||| S:164 E:167 ||| DT
increase  ||| S:167 E:176 ||| NN
in  ||| S:176 E:179 ||| IN
cancer  ||| S:179 E:186 ||| NN
patient  ||| S:186 E:194 ||| NN
referrals  ||| S:194 E:204 ||| NNS
to  ||| S:204 E:207 ||| TO
our  ||| S:207 E:211 ||| PRP$
palliative  ||| S:211 E:222 ||| JJ
care  ||| S:222 E:227 ||| NN
team  ||| S:227 E:232 ||| NN
during  ||| S:232 E:239 ||| IN
a  ||| S:239 E:241 ||| DT
cancer  ||| S:241 E:248 ||| NN
treatment ||| S:248 E:257 ||| NN
.  ||| S:257 E:259 ||| .
In  ||| S:259 E:262 ||| IN
order  ||| S:262 E:268 ||| NN
to  ||| S:268 E:271 ||| TO
help  ||| S:271 E:276 ||| VB
an  ||| S:276 E:279 ||| DT
end-of-life  ||| S:279 E:291 ||| JJ
stage  ||| S:291 E:297 ||| NN
homecare  ||| S:297 E:306 ||| NN
cancer  ||| S:306 E:313 ||| NN
patient  ||| S:313 E:321 ||| NN
who  ||| S:321 E:325 ||| WP
becomes  ||| S:325 E:333 ||| VBZ
being  ||| S:333 E:339 ||| VBG
depressed  ||| S:339 E:349 ||| JJ
and  ||| S:349 E:353 ||| CC
the  ||| S:353 E:357 ||| DT
family  ||| S:357 E:364 ||| NN
being  ||| S:364 E:370 ||| VBG
felt  ||| S:370 E:375 ||| VBN
restlessness ||| S:375 E:387 ||| NN
,  ||| S:387 E:389 ||| ,
a  ||| S:389 E:391 ||| DT
fine-tuned  ||| S:391 E:402 ||| JJ
response ||| S:402 E:410 ||| NN
,  ||| S:410 E:412 ||| ,
an  ||| S:412 E:415 ||| DT
early  ||| S:415 E:421 ||| JJ
stage  ||| S:421 E:427 ||| NN
of  ||| S:427 E:430 ||| IN
revelation  ||| S:430 E:441 ||| NN
of  ||| S:441 E:444 ||| IN
the  ||| S:444 E:448 ||| DT
disease  ||| S:448 E:456 ||| NN
and  ||| S:456 E:460 ||| CC
treatment  ||| S:460 E:470 ||| NN
are  ||| S:470 E:474 ||| VBP
essential  ||| S:474 E:484 ||| JJ
to  ||| S:484 E:487 ||| TO
have  ||| S:487 E:492 ||| VB
a  ||| S:492 E:494 ||| DT
long  ||| S:494 E:499 ||| JJ
lasting  ||| S:499 E:507 ||| JJ
homecare  ||| S:507 E:516 ||| JJ
environment ||| S:516 E:527 ||| NN
.  ||| S:527 E:529 ||| .
Based  ||| S:529 E:535 ||| VBN
on  ||| S:535 E:538 ||| IN
the  ||| S:538 E:542 ||| DT
Basic  ||| S:542 E:548 ||| JJ
Plan  ||| S:548 E:553 ||| NN
to  ||| S:553 E:556 ||| TO
Promote  ||| S:556 E:564 ||| NNP
Cancer  ||| S:564 E:571 ||| NNP
Control  ||| S:571 E:579 ||| NNP
Programs ||| S:579 E:587 ||| NNP
,  ||| S:587 E:589 ||| ,
our  ||| S:589 E:593 ||| PRP$
hospital  ||| S:593 E:602 ||| NN
established  ||| S:602 E:614 ||| VBD
a  ||| S:614 E:616 ||| DT
cancer  ||| S:616 E:623 ||| NN
consulting  ||| S:623 E:634 ||| NN
support  ||| S:634 E:642 ||| NN
center  ||| S:642 E:649 ||| NN
and  ||| S:649 E:653 ||| CC
a  ||| S:653 E:655 ||| DT
palliative  ||| S:655 E:666 ||| JJ
cancer  ||| S:666 E:673 ||| NN
care  ||| S:673 E:678 ||| NN
team  ||| S:678 E:683 ||| NN
in  ||| S:683 E:686 ||| IN
June  ||| S:686 E:691 ||| NNP
2009 ||| S:691 E:695 ||| CD
,  ||| S:695 E:697 ||| ,
and  ||| S:697 E:701 ||| CC
staffed  ||| S:701 E:709 ||| VBN
them  ||| S:709 E:714 ||| PRP
with  ||| S:714 E:719 ||| IN
multidisciplinary  ||| S:719 E:737 ||| JJ
personnel ||| S:737 E:746 ||| NNS
.  ||| S:746 E:748 ||| .
With  ||| S:748 E:753 ||| IN
medical  ||| S:753 E:761 ||| JJ
staffs  ||| S:761 E:768 ||| NNS
involved  ||| S:768 E:777 ||| VBN
as  ||| S:777 E:780 ||| IN
a  ||| S:780 E:782 ||| DT
team ||| S:782 E:786 ||| NN
,  ||| S:786 E:788 ||| ,
we  ||| S:788 E:791 ||| PRP
considered  ||| S:791 E:802 ||| VBD
a  ||| S:802 E:804 ||| DT
shared  ||| S:804 E:811 ||| JJ
decision  ||| S:811 E:820 ||| NN
making  ||| S:820 E:827 ||| VBG
repeatedly  ||| S:827 E:838 ||| RB
in  ||| S:838 E:841 ||| IN
compliance  ||| S:841 E:852 ||| NN
with  ||| S:852 E:857 ||| IN
in-patient ||| S:857 E:867 ||| NNP
's  ||| S:867 E:870 ||| POS
wishes  ||| S:870 E:877 ||| NNS
for  ||| S:877 E:881 ||| IN
home  ||| S:881 E:886 ||| NN
care ||| S:886 E:890 ||| NN
.  ||| S:890 E:892 ||| .
One  ||| S:892 E:896 ||| CD
of  ||| S:896 E:899 ||| IN
the  ||| S:899 E:903 ||| DT
problems  ||| S:903 E:912 ||| NNS
we  ||| S:912 E:915 ||| PRP
have  ||| S:915 E:920 ||| VBP
experienced  ||| S:920 E:932 ||| VBN
was  ||| S:932 E:936 ||| VBD
that  ||| S:936 E:941 ||| IN
a  ||| S:941 E:943 ||| DT
patient  ||| S:943 E:951 ||| NN
would  ||| S:951 E:957 ||| MD
take  ||| S:957 E:962 ||| VB
a  ||| S:962 E:964 ||| DT
long  ||| S:964 E:969 ||| JJ
time  ||| S:969 E:974 ||| NN
for  ||| S:974 E:978 ||| IN
a  ||| S:978 E:980 ||| DT
decision  ||| S:980 E:989 ||| NN
making  ||| S:989 E:996 ||| VBG
due  ||| S:996 E:1000 ||| JJ
to  ||| S:1000 E:1003 ||| TO
the  ||| S:1003 E:1007 ||| DT
state  ||| S:1007 E:1013 ||| NN
of  ||| S:1013 E:1016 ||| IN
mental  ||| S:1016 E:1023 ||| JJ
depression ||| S:1023 E:1033 ||| NN
,  ||| S:1033 E:1035 ||| ,
even  ||| S:1035 E:1040 ||| RB
if  ||| S:1040 E:1043 ||| IN
the  ||| S:1043 E:1047 ||| DT
patient  ||| S:1047 E:1055 ||| NN
had  ||| S:1055 E:1059 ||| VBD
an  ||| S:1059 E:1062 ||| DT
ability  ||| S:1062 E:1070 ||| NN
to  ||| S:1070 E:1073 ||| TO
think  ||| S:1073 E:1079 ||| VB
and  ||| S:1079 E:1083 ||| CC
evaluate  ||| S:1083 E:1092 ||| VB
oneself ||| S:1092 E:1099 ||| PRP
.  ||| S:1099 E:1101 ||| .
For  ||| S:1101 E:1105 ||| IN
a  ||| S:1105 E:1107 ||| DT
medicinal  ||| S:1107 E:1117 ||| JJ
treatment  ||| S:1117 E:1127 ||| NN
of  ||| S:1127 E:1130 ||| IN
cancer  ||| S:1130 E:1137 ||| NN
patient  ||| S:1137 E:1145 ||| NN
with  ||| S:1145 E:1150 ||| IN
the  ||| S:1150 E:1154 ||| DT
state  ||| S:1154 E:1160 ||| NN
of  ||| S:1160 E:1163 ||| IN
depression ||| S:1163 E:1173 ||| NN
,  ||| S:1173 E:1175 ||| ,
steroid ||| S:1175 E:1182 ||| NN
,  ||| S:1182 E:1184 ||| ,
interferon ||| S:1184 E:1194 ||| NN
,  ||| S:1194 E:1196 ||| ,
hypertension  ||| S:1196 E:1209 ||| JJ
drug ||| S:1209 E:1213 ||| NN
,  ||| S:1213 E:1215 ||| ,
female  ||| S:1215 E:1222 ||| JJ
hormone  ||| S:1222 E:1230 ||| NN
pill ||| S:1230 E:1234 ||| NN
,  ||| S:1234 E:1236 ||| ,
anti-histamine  ||| S:1236 E:1251 ||| JJ
medicine  ||| S:1251 E:1260 ||| NN
and  ||| S:1260 E:1264 ||| CC
anti-fungus  ||| S:1264 E:1276 ||| JJ
agent  ||| S:1276 E:1282 ||| NN
will  ||| S:1282 E:1287 ||| MD
cause  ||| S:1287 E:1293 ||| VB
frequent  ||| S:1293 E:1302 ||| JJ
side  ||| S:1302 E:1307 ||| NN
effects ||| S:1307 E:1314 ||| NNS
,  ||| S:1314 E:1316 ||| ,
but  ||| S:1316 E:1320 ||| CC
they  ||| S:1320 E:1325 ||| PRP
are  ||| S:1325 E:1329 ||| VBP
easy  ||| S:1329 E:1334 ||| JJ
to  ||| S:1334 E:1337 ||| TO
get  ||| S:1337 E:1341 ||| VB
rid  ||| S:1341 E:1345 ||| VBN
of  ||| S:1345 E:1348 ||| IN
the  ||| S:1348 E:1352 ||| DT
symptoms ||| S:1352 E:1360 ||| NNS
.  ||| S:1360 E:1362 ||| .
It  ||| S:1362 E:1365 ||| PRP
appears  ||| S:1365 E:1373 ||| VBZ
that  ||| S:1373 E:1378 ||| IN
5-percent  ||| S:1378 E:1388 ||| CD
of  ||| S:1388 E:1391 ||| IN
the  ||| S:1391 E:1395 ||| DT
patients  ||| S:1395 E:1404 ||| NNS
who  ||| S:1404 E:1408 ||| WP
had  ||| S:1408 E:1412 ||| VBD
steroid  ||| S:1412 E:1420 ||| CD
administered  ||| S:1420 E:1433 ||| CD
10  ||| S:1433 E:1436 ||| CD
days  ||| S:1436 E:1441 ||| NNS
ago  ||| S:1441 E:1445 ||| RB
have  ||| S:1445 E:1450 ||| VB
a  ||| S:1450 E:1452 ||| DT
tendency  ||| S:1452 E:1461 ||| NN
to  ||| S:1461 E:1464 ||| TO
have  ||| S:1464 E:1469 ||| VB
a  ||| S:1469 E:1471 ||| DT
high  ||| S:1471 E:1476 ||| JJ
manifested  ||| S:1476 E:1487 ||| JJ
risk  ||| S:1487 E:1492 ||| NN
in  ||| S:1492 E:1495 ||| IN
40mg ||| S:1495 E:1499 ||| CD
/ ||| S:1499 E:1500 ||| CD
day  ||| S:1500 E:1504 ||| NN
PURRE-  ||| S:1504 E:1511 ||| NNP
DONIZORO ||| S:1511 E:1519 ||| NNP
/ ||| S:1519 E:1520 ||| NNP
Japan  ||| S:1520 E:1526 ||| NNP
calculated ||| S:1526 E:1536 ||| VBD
.  ||| S:1536 E:1538 ||| .
In  ||| S:1538 E:1541 ||| IN
case  ||| S:1541 E:1546 ||| NN
of  ||| S:1546 E:1549 ||| IN
medication  ||| S:1549 E:1560 ||| JJ
related  ||| S:1560 E:1568 ||| JJ
depression ||| S:1568 E:1578 ||| NN
,  ||| S:1578 E:1580 ||| ,
the  ||| S:1580 E:1584 ||| DT
symptom  ||| S:1584 E:1592 ||| NN
can  ||| S:1592 E:1596 ||| MD
be  ||| S:1596 E:1599 ||| VB
rather  ||| S:1599 E:1606 ||| RB
controlled  ||| S:1606 E:1617 ||| VBN
quickly  ||| S:1617 E:1625 ||| RB
by  ||| S:1625 E:1628 ||| IN
a  ||| S:1628 E:1630 ||| DT
decrease  ||| S:1630 E:1639 ||| NN
in  ||| S:1639 E:1642 ||| IN
the  ||| S:1642 E:1646 ||| DT
amount  ||| S:1646 E:1653 ||| NN
of  ||| S:1653 E:1656 ||| IN
medication ||| S:1656 E:1666 ||| NN
.  ||| S:1666 E:1668 ||| .
On  ||| S:1668 E:1671 ||| IN
the  ||| S:1671 E:1675 ||| DT
other  ||| S:1675 E:1681 ||| JJ
hand ||| S:1681 E:1685 ||| NN
,  ||| S:1685 E:1687 ||| ,
there  ||| S:1687 E:1693 ||| EX
is  ||| S:1693 E:1696 ||| VBZ
a  ||| S:1696 E:1698 ||| DT
possibility  ||| S:1698 E:1710 ||| NN
that  ||| S:1710 E:1715 ||| IN
side  ||| S:1715 E:1720 ||| NN
effects  ||| S:1720 E:1728 ||| NNS
may  ||| S:1728 E:1732 ||| MD
appear  ||| S:1732 E:1739 ||| VB
before  ||| S:1739 E:1746 ||| IN
anti-depression  ||| S:1746 E:1762 ||| NNP
comes  ||| S:1762 E:1768 ||| VBZ
to  ||| S:1768 E:1771 ||| TO
effects  ||| S:1771 E:1779 ||| NNS
in  ||| S:1779 E:1782 ||| IN
case  ||| S:1782 E:1787 ||| NN
of  ||| S:1787 E:1790 ||| IN
an  ||| S:1790 E:1793 ||| DT
ordinary  ||| S:1793 E:1802 ||| JJ
depression  ||| S:1802 E:1813 ||| NN
case ||| S:1813 E:1817 ||| NN
.  ||| S:1817 E:1819 ||| .
And  ||| S:1819 E:1823 ||| CC
it  ||| S:1823 E:1826 ||| PRP
takes  ||| S:1826 E:1832 ||| VBZ
2-4  ||| S:1832 E:1836 ||| CD
weeks  ||| S:1836 E:1842 ||| NNS
for  ||| S:1842 E:1846 ||| IN
the  ||| S:1846 E:1850 ||| DT
medicine  ||| S:1850 E:1859 ||| NN
to  ||| S:1859 E:1862 ||| TO
be  ||| S:1862 E:1865 ||| VB
effective ||| S:1865 E:1874 ||| JJ
.  ||| S:1874 E:1876 ||| .
Therefore ||| S:1876 E:1885 ||| RB
,  ||| S:1885 E:1887 ||| ,
amid  ||| S:1887 E:1892 ||| IN
the  ||| S:1892 E:1896 ||| DT
cancer  ||| S:1896 E:1903 ||| NN
patient  ||| S:1903 E:1911 ||| NN
is  ||| S:1911 E:1914 ||| VBZ
being  ||| S:1914 E:1920 ||| VBG
in  ||| S:1920 E:1923 ||| IN
the  ||| S:1923 E:1927 ||| DT
state  ||| S:1927 E:1933 ||| NN
of  ||| S:1933 E:1936 ||| IN
depression ||| S:1936 E:1946 ||| NN
,  ||| S:1946 E:1948 ||| ,
a  ||| S:1948 E:1950 ||| DT
decision  ||| S:1950 E:1959 ||| NN
to  ||| S:1959 E:1962 ||| TO
transfer  ||| S:1962 E:1971 ||| VB
the  ||| S:1971 E:1975 ||| DT
patient  ||| S:1975 E:1983 ||| NN
for  ||| S:1983 E:1987 ||| IN
home  ||| S:1987 E:1992 ||| NN
care  ||| S:1992 E:1997 ||| NN
environment  ||| S:1997 E:2009 ||| NN
should  ||| S:2009 E:2016 ||| MD
be  ||| S:2016 E:2019 ||| VB
delayed ||| S:2019 E:2026 ||| VBN
.  ||| S:2026 E:2028 ||| .
This  ||| S:2028 E:2033 ||| DT
is  ||| S:2033 E:2036 ||| VBZ
why  ||| S:2036 E:2040 ||| WRB
we  ||| S:2040 E:2043 ||| PRP
ought  ||| S:2043 E:2049 ||| MD
to  ||| S:2049 E:2052 ||| TO
investigate  ||| S:2052 E:2064 ||| VB
it  ||| S:2064 E:2067 ||| PRP
as  ||| S:2067 E:2070 ||| IN
one  ||| S:2070 E:2074 ||| CD
of  ||| S:2074 E:2077 ||| IN
the  ||| S:2077 E:2081 ||| DT
problems  ||| S:2081 E:2090 ||| NNS
in  ||| S:2090 E:2093 ||| IN
palliative  ||| S:2093 E:2104 ||| JJ
care ||| S:2104 E:2108 ||| NN
.  ||| S:2108 E:2110 ||| .
In  ||| S:2110 E:2113 ||| IN
conclusion ||| S:2113 E:2123 ||| NN
,  ||| S:2123 E:2125 ||| ,
due  ||| S:2125 E:2129 ||| JJ
to  ||| S:2129 E:2132 ||| TO
a  ||| S:2132 E:2134 ||| DT
patient ||| S:2134 E:2141 ||| NN
's  ||| S:2141 E:2144 ||| POS
inability  ||| S:2144 E:2154 ||| NN
to  ||| S:2154 E:2157 ||| TO
make  ||| S:2157 E:2162 ||| VB
own  ||| S:2162 E:2166 ||| JJ
decision ||| S:2166 E:2174 ||| NN
,  ||| S:2174 E:2176 ||| ,
or  ||| S:2176 E:2179 ||| CC
for  ||| S:2179 E:2183 ||| IN
a  ||| S:2183 E:2185 ||| DT
home  ||| S:2185 E:2190 ||| NN
care  ||| S:2190 E:2195 ||| NN
period  ||| S:2195 E:2202 ||| NN
to  ||| S:2202 E:2205 ||| TO
be  ||| S:2205 E:2208 ||| VB
not  ||| S:2208 E:2212 ||| RB
shortened ||| S:2212 E:2221 ||| VBN
,  ||| S:2221 E:2223 ||| ,
or  ||| S:2223 E:2226 ||| CC
we  ||| S:2226 E:2229 ||| PRP
fail  ||| S:2229 E:2234 ||| VBP
to  ||| S:2234 E:2237 ||| TO
make  ||| S:2237 E:2242 ||| VB
a  ||| S:2242 E:2244 ||| DT
right  ||| S:2244 E:2250 ||| JJ
timing  ||| S:2250 E:2257 ||| NN
to  ||| S:2257 E:2260 ||| TO
for  ||| S:2260 E:2264 ||| IN
sending  ||| S:2264 E:2272 ||| VBG
the  ||| S:2272 E:2276 ||| DT
patient  ||| S:2276 E:2284 ||| NN
to  ||| S:2284 E:2287 ||| TO
home ||| S:2287 E:2291 ||| NN
,  ||| S:2291 E:2293 ||| ,
a  ||| S:2293 E:2295 ||| DT
careful  ||| S:2295 E:2303 ||| JJ
daily  ||| S:2303 E:2309 ||| JJ
observation  ||| S:2309 E:2321 ||| NN
and  ||| S:2321 E:2325 ||| CC
a  ||| S:2325 E:2327 ||| DT
fine-tuned  ||| S:2327 E:2338 ||| JJ
response  ||| S:2338 E:2347 ||| NN
are  ||| S:2347 E:2351 ||| VBP
desired  ||| S:2351 E:2359 ||| VBN
for  ||| S:2359 E:2363 ||| IN
a  ||| S:2363 E:2365 ||| DT
sign  ||| S:2365 E:2370 ||| NN
of  ||| S:2370 E:2373 ||| IN
depression  ||| S:2373 E:2384 ||| NN
with  ||| S:2384 E:2389 ||| IN
the  ||| S:2389 E:2393 ||| DT
cancer  ||| S:2393 E:2400 ||| NN
patient ||| S:2400 E:2407 ||| NN
.  ||| S:2407 E:2409 ||| .
